Solid Start for Analytik Jena AG

Analytik Jena AG moved into the 2015 financial year with significantly increased order entries totaling EUR 32.1 m (previous year: EUR 25.4 m) and a profit of EUR 0.7 m (previous year: EUR -1.5 m) for the period ending on March 31, 2015. The positive result for the period was generated solely by the Analytical Instrumentation business unit, while the other segments still posted negative figures in the first quarter of 2015.

“After a disappointing performance in the past calendar year 2014, in which we were unable to grow sales or generate a positive result, the tide is clearly turning in the first quarter of the 2015 financial year,” said Klaus Berka, CEO of Analytik Jena AG. “In the two core areas of the instrument business, Analytical Instrumentation and Life Science, we’ve managed to achieve double-digit increases in order entries and revenue compared to the previous year. Analytik Jena ended the period with both a positive operating profit and overall result at the Group level.”

Two major orders in the first quarter with a total sales volume of EUR 2.5 m were acquired in China, the Company’s most important export market; revenue of approximately EUR 110.0 m in the instrument business (not including project business) and an operating profit of EUR 4.0 m to EUR 5.0 m are expected for the 2015 financial year.

The situation in Optics and the project business, in the form of its 50% subsidiary AJZ Engineering, remains difficult despite solid order entries for its consumer business under the DOCTER ^® brand. Continued tension in Russia, a key market were said to account for lower sales in the Project Business unit compared to same period last year.